The Colder Fluids - Intravenous Infusion of 10 Degrees Celsius Fluids and Its Effects on Circulation and Hemostasis

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 6, 2023

Primary Completion Date

December 20, 2023

Study Completion Date

December 20, 2023

Conditions
Hemodynamic Instability
Interventions
DRUG

Ringer's Lactate

"On the first trial day healthy volunteers are randomized to receive 1 liter of Ringer's lactate either cold (10°C, 50°F), or at room temperature (22°C, 71.6°F) with 100 ml/min. After a minimum washout period of 24 hours, subjects are switched to receive infusion at the other aforementioned temperatures."

Trial Locations (1)

5000

Odense University Hospital, Odense

All Listed Sponsors
collaborator

Odense University Hospital

OTHER

lead

Esbjerg Hospital - University Hospital of Southern Denmark

OTHER

NCT06622499 - The Colder Fluids - Intravenous Infusion of 10 Degrees Celsius Fluids and Its Effects on Circulation and Hemostasis | Biotech Hunter | Biotech Hunter